Investigational Drug Management

Level 2

  • 1

    Module 1: Drug Supplies – IMP and Comparators

    • Module 1: Drug Supplies – IMP and Comparators
  • 2

    Module 2: Drug randomisation and Blinding

    • Module 2: Drug randomisation and Blinding
  • 3

    Module 3: Drug distribution and management at sites (inc drug accountability)

    • slide 2

    • slide 3_1

    • slide 4

    • slide 5

    • slide 6_1

    • slide 7

    • slide 8_1

    • slide 9_2

    • Knowledge Checkpoints 01

    • slide 10

    • slide 11

    • slide 12_1

    • slide 13_1

    • slide 14_1

    • slide 15_1

    • Knowledge Checkpoints 02

    • slide 16_1

    • slide 17

    • slide 18_1

    • slide 19

    • slide 20

    • slide 21

    • slide 22

    • Knowledge Checkpoints 03

    • slide 23_2

Instructor

Chief Operating Officer

Dr Tina Barton

Dr. Tina Barton, Chief Operating Officer of eMQT, is a drug development specialist with over 40 years’ experience, working in partnership to lead for success as a customer-focused senior leader. During this time Dr. Barton has invested in training for the future – through team leadership, individual mentoring and training thereby sharing knowledge and developing professionals. Through her role at the Institute of Clinical Research she continues to support and lead training activities. With a passion for transformation, Dr. Barton drove the embracement of Central Eastern European countries and now is focused on the inclusion of Sub-Saharan Africa into clinical development – bringing the miracle of development of new medicines to emerging markets and new patients. Dr. Barton holds a BSc, PhD and MBA alongside over 50 academic publications and is an Honorary Fellow, and Board Member of the Institute of Clinical Research.